Home Credit Ratings and Research Fitch Research McKesson Corp

Fitch: McKesson's 'BBB+' Ratings Unchanged On Rexall, Oncology Acquisitions

Published Mar 02, 2016

1678 words — Published Mar 02, 2016

Price US$ 149.00 | Buy this Report Now

About This Report

Brief Excerpt:

Fitch: McKesson's 'BBB+' Ratings Unchanged On Rexall, Oncology Acquisitions 02 Mar 2016 4:28 PM (EST) Fitch Ratings-Chicago-02 March 2016: The ratings for McKesson Corp. (NYSE: MCK), including the 'BBB+' Long-term Issuer Default Rating...

Report Type:

Press Release

Company(ies)

McKesson Corp

Format:

HTML

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author

Cite this Report


MLA:	Fitch Research. "Fitch: McKesson's 'BBB+' Ratings Unchanged On Rexall, Oncology Acquisitions" Mar 02, 2016. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-McKesson-s-BBB-Ratings-Unchanged-On-Rexall-Oncology-Acquisitions-1000358_pr_frame>

APA:	Fitch Research. (). Fitch: McKesson's 'BBB+' Ratings Unchanged On Rexall, Oncology Acquisitions Mar 02, 2016. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-McKesson-s-BBB-Ratings-Unchanged-On-Rexall-Oncology-Acquisitions-1000358_pr_frame>

US$ 149.00

$ £ €

Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

Example Report

Click to View Sample Report

More Research

Search all our Credit Research from one place.